Full-Time

Senior Director

Regulatory Affairs

Confirmed live in the last 24 hours

Adaptive Biotechnologies

Adaptive Biotechnologies

501-1,000 employees

Decodes immune cell genetic information for diagnostics

Biotechnology
Healthcare

Compensation Overview

$204.3k - $306.5kAnnually

+ Equity Grant + Bonus

Senior, Expert

No H1B Sponsorship

Remote in USA

Category
Legal
Risk & Compliance
Legal & Compliance

You match the following Adaptive Biotechnologies's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • BA/BS undergraduate degree in life sciences. MS, PhD or other relevant advanced degree strongly preferred.
  • 17+ years (14+ with MS, or 10+ with PhD) of progressive management experience in global regulatory affairs in a diagnostic, medical device or life sciences technology-driven company.
  • In vitro diagnostics (IVD) experience required.
  • Experience with diagnostic product regulatory submissions in relevant therapeutic areas (hematology, oncology, immunology); experience with next-generation sequencing or similar high complexity diagnostic products highly preferred.
  • Experience in strategic planning and collaboration with executives, key operational groups and external partners.
  • Expertise with all phases of the product development lifecycle, including feasibility, design, development, transfer, verification and validation activities necessary for research and diagnostic product commercialization.
  • Extensive experience in ISO, CLIA, CAP, CLEP, GxP and other Regulatory compliance requirements.
  • Proven hands-on experience in submission and approval of US regulatory filings and reporting including US PMA, de novo, IDE, and 510(k) filings; cDx experience highly preferred.
  • Relationships with and ability to personally engage current CDRH leadership highly preferred.
  • Knowledge of and direct experience with market entry strategies, regulatory pathways and approval process in other key countries/regions globally (e.g., Canada, major European markets, Japan, Australia, China).
  • History of successful direct interactions and negotiations with regulatory agencies.
  • Experience directly implementing or partnering with Quality leadership to implement and managing quality/compliance systems and ensuring inspection readiness in alignment with requirements of global regulatory authorities.
Responsibilities
  • Provide management and leadership to the Regulatory Affairs team in the development and implementation of regulatory strategies and processes.
  • Lead the planning and preparation for meetings with regulatory agencies, and represent Adaptive during meetings and negotiations with regulatory agencies.
  • Monitor, interpret and communicate any emerging regulations, global regulatory trends, and guidelines. Assess their impact on Adaptive’s products and operations and bring forward findings and recommendations.
  • Monitor competitors’ regulatory activities and changes to anticipate potential impacts on the Adaptive’s products and regulatory strategies.
  • Oversee preparation and filing of all regulatory documents with the FDA and international regulatory agencies, within applicable regulations and guidelines; ultimate responsibility for reviewing and approving relevant regulatory filing documentation.
  • Assume responsibility for regulatory component of IVDR compliance.
  • Provide counsel, training and interpretation of FDA and global regulatory requirements to all company personnel.
  • Provide regulatory oversight and guidance for compliant product promotion.
  • Serve as primary contact responsible for communications with the U.S. and global regulatory agencies. Develop and maintain external relationships with relevant opinion leaders and regulatory officials.
  • Identify and assess regulatory risks related to planned clinical development activities; develop mitigation strategies and work closely with cross-functional teams to ensure risk assessments are integrated into product development and lifecycle management processes.
  • Leverage knowledge of pharma drug development trends and evolving regulatory agency viewpoints on MRD in hematology to inform a forward-looking regulatory strategy that supports expansion of Adaptive’s MRD pharma business.
  • Work cross-functionally with collaborators to support delivery of pharma partner regulatory requirements, including clinical trials IDEs and other relevant applications.
  • Understand and translate regulatory intelligence, scientific, operational and business knowledge into effective strategy and implementation plans for key product development initiatives.
  • Direct the development of systems, practices and processes to ensure effective ongoing review of product design or other operational and manufacturing changes.
  • Partner with Quality to oversee post-market regulatory surveillance, and reporting, and regulatory audits to ensure compliance and optimal market access.
  • Set and maintain regulatory policies and standard operating procedures (SOPs) to ensure compliance with applicable regulations worldwide. Train cross functional teams accordingly.
  • Provide leadership, direction and oversight to manage regulatory policy deviation events that may impact compliance status or create business risk.
  • Serve as a member of the Quality Management Review team.
Desired Qualifications
  • Experience with next-generation sequencing or similar high complexity diagnostic products highly preferred.
  • cDx experience highly preferred.
  • Relationships with and ability to personally engage current CDRH leadership highly preferred.
Adaptive Biotechnologies

Adaptive Biotechnologies

View

Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand how the immune system reacts to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies uses advanced data algorithms to analyze immune cell genetics and generates revenue through partnerships with pharmaceutical companies, licensing technology, and offering diagnostic services. Their goal is to leverage immune system data to advance healthcare and develop effective therapies for various diseases.

Company Stage

IPO

Total Funding

$395.8M

Headquarters

Seattle, Washington

Founded

2009

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-3%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strong investor confidence with investments from firms like Jacobs Levy and Acadian Asset Management.
  • Partnership with EndoSound could expand product offerings in the medical device market.
  • Recognition as Workplace of the Year highlights a strong company culture attracting top talent.

What critics are saying

  • Emerging competition from startups like Adaptive with $20 million funding for AI applications.
  • Regulatory hurdles in developing new medical devices with EndoSound partnership.
  • Pressure from investors for rapid financial returns may impact long-term R&D.

What makes Adaptive Biotechnologies unique

  • Adaptive Biotechnologies leverages immune system data for disease diagnosis and treatment.
  • Their clonoSEQ test is FDA-authorized for monitoring minimal residual disease in blood cancers.
  • The ImmuneRACE study enhances understanding of immune responses to COVID-19.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Performance Bonus